Monosialoganglioside Preventing Neurotoxicity Induced by Albumin-bound Paclitaxel Chemotherapy in Lung Cancer Patients
Clinical trial NCT02500810 · UNKNOWN
Trial details
- NCT number
- NCT02500810
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2018-07-01
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.